A detailed history of Teza Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Teza Capital Management LLC holds 5,036 shares of ABBV stock, worth $906,480. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,036
Previous 1,407 257.92%
Holding current value
$906,480
Previous $241,000 312.45%
% of portfolio
0.11%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $594,575 - $723,368
3,629 Added 257.92%
5,036 $994,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $217,789 - $254,329
1,407 New
1,407 $241,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.41 Million - $1.59 Million
10,239 Added 118.44%
18,884 $2.93 Million
Q3 2023

Feb 22, 2024

SELL
$133.59 - $154.65 $6.47 Million - $7.49 Million
-48,455 Reduced 90.9%
4,852 $723,000
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $10.5 Million - $12.1 Million
-78,338 Reduced 90.06%
8,645 $1.29 Million
Q2 2023

Feb 22, 2024

BUY
$132.51 - $164.9 $4.56 Million - $5.68 Million
34,423 Added 182.29%
53,307 $7.18 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $11.3 Million - $14 Million
84,950 Added 4178.55%
86,983 $11.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $174,688 - $201,180
-1,208 Reduced 37.27%
2,033 $323,000
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $448,262 - $537,584
3,241 New
3,241 $524,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $2.64 Million - $3.28 Million
-20,012 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $1.74 Million - $2.2 Million
16,154 Added 418.71%
20,012 $2.71 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $5.65 Million - $6.41 Million
-53,076 Reduced 93.22%
3,858 $416,000
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $5.99 Million - $6.67 Million
56,934 New
56,934 $6.41 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $688,274 - $757,707
-6,728 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $1.54 Million - $2.08 Million
-19,123 Reduced 73.97%
6,728 $721,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $2.22 Million - $2.61 Million
25,851 New
25,851 $2.26 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $966,629 - $1.07 Million
-10,872 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $20,559 - $24,326
229 Added 2.15%
10,872 $1.01 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $228,092 - $305,437
2,479 Added 30.37%
10,643 $1.01 Million
Q4 2017

Aug 14, 2018

BUY
$89.56 - $98.21 $61,169 - $67,077
683 Added 9.13%
8,164 $790,000
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $669,998 - $734,709
7,481
7,481 $723,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Teza Capital Management LLC Portfolio

Follow Teza Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.